April 9, 2019
Breakthrough T1D Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
March 22, 2019
Breakthrough T1D Statement on FDA Complete Response Letter for Zynquista™
March 5, 2019
Breakthrough T1D Statement on Eli Lilly Announcement of a New, Lower Cost Generic Insulin
March 5, 2019
Antolrx Announces Pfizer Exercises Option to License Immune Tolerance Therapy For Potential Treatment of Type 1 Diabetes
February 4, 2019
Breakthrough T1D STATEMENT ON UNITED HEALTHCARE INSULIN PUMP AGREEMENT WITH MEDTRONIC
January 31, 2019
Breakthrough T1D Statement on the United States Department of Health and Human Services Announcement on Drug Rebates
January 31, 2019
Breakthrough T1D Leads Research to Develop a Vaccine for Viral Infections That Could Prevent Type 1 Diabetes
January 16, 2019
Breakthrough T1D Ambassador Eric Tozer set to participate in the 2019 World Marathon Challenge
December 20, 2018
Breakthrough T1D Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science
December 20, 2018
